Transport deficiency is the molecular basis of \(Candida\) \(albicans\) resistance to antifungal oligopeptides
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Microbiology (2017) 8:2154. https://doi.org/10.3389/fmicb.2017.02154
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2021
- Urheber
-
Schielmann, Marta
Szweda, Piotr
Gucwa, Katarzyna
Kawczyński, Marcin
Milewska, Maria J.
Martynow, Dorota
Morschhäuser, Joachim
Milewski, Sławomir
- DOI
-
10.3389/fmicb.2017.02154
- URN
-
urn:nbn:de:bvb:20-opus-173245
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schielmann, Marta
- Szweda, Piotr
- Gucwa, Katarzyna
- Kawczyński, Marcin
- Milewska, Maria J.
- Martynow, Dorota
- Morschhäuser, Joachim
- Milewski, Sławomir
- Universität Würzburg
Entstanden
- 2021
Ähnliche Objekte (12)
Candida albicans and Antifungal Peptides
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Candida albicans and Antifungal Peptides
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Candida albicans and Antifungal Peptides
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A